These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8251589

  • 1. Macrophages in experimental Chagas' disease.
    Kuhn RE.
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [Abstract] [Full Text] [Related]

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M, de Titto E.
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [Abstract] [Full Text] [Related]

  • 3. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
    Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Zoulika K, Ouaissi A.
    J Immunol; 1998 Apr 01; 160(7):3471-9. PubMed ID: 9531308
    [Abstract] [Full Text] [Related]

  • 4. Rat models to investigate host macrophage defense against Trypanosoma cruzi.
    Fabrino DL, Leon LL, Genestra M, Parreira GG, Melo RC.
    J Innate Immun; 2011 Apr 01; 3(1):71-82. PubMed ID: 21051863
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A, Ouaissi M.
    Arch Immunol Ther Exp (Warsz); 2005 Apr 01; 53(2):102-14. PubMed ID: 15928579
    [Abstract] [Full Text] [Related]

  • 6. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages.
    Ramos-Ligonio A, López-Monteon A, Talamás-Rohana P, Rosales-Encina JL.
    Parasite Immunol; 2004 Oct 01; 26(10):409-18. PubMed ID: 15752118
    [Abstract] [Full Text] [Related]

  • 7. Trypanosoma cruzi: infectivity and virulence of trypomastigotes incubated with leukocytes and serum from patients with Chagas' disease.
    Mosca W, Briceño L, Velasco J.
    Acta Cient Venez; 1992 Oct 01; 43(5):290-4. PubMed ID: 1343741
    [Abstract] [Full Text] [Related]

  • 8. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
    Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, Aoki Mdel P, Bottasso O, Guiñazú N, Silva-Barbosa SD, Gea S.
    Cytokine Growth Factor Rev; 2007 Oct 01; 18(1-2):107-24. PubMed ID: 17339126
    [Abstract] [Full Text] [Related]

  • 9. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS, Alcantara A, Brener Z.
    Tropenmed Parasitol; 1981 Jun 01; 32(2):93-6. PubMed ID: 6789512
    [Abstract] [Full Text] [Related]

  • 10. Immune system recognition of Trypanosoma cruzi.
    Tarleton RL.
    Curr Opin Immunol; 2007 Aug 01; 19(4):430-4. PubMed ID: 17651955
    [Abstract] [Full Text] [Related]

  • 11. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection.
    Hideko Tatakihara VL, Cecchini R, Borges CL, Malvezi AD, Graça-de Souza VK, Yamada-Ogatta SF, Rizzo LV, Pinge-Filho P.
    FEMS Immunol Med Microbiol; 2008 Jan 01; 52(1):47-58. PubMed ID: 18031539
    [Abstract] [Full Text] [Related]

  • 12. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Jan 01; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 13. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease.
    Borges CL, Cecchini R, Tatakihara VL, Malvezi AD, Yamada-Ogatta SF, Rizzo LV, Pinge-Filho P.
    Immunol Lett; 2009 Mar 24; 123(1):38-45. PubMed ID: 19428550
    [Abstract] [Full Text] [Related]

  • 14. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages.
    Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF.
    Nature; 2000 Jan 13; 403(6766):199-203. PubMed ID: 10646605
    [Abstract] [Full Text] [Related]

  • 15. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM, Martins-Filho OA, Reis AB, Veloso VM, Araújo FM, Bahia MT, de Lana M, Machado-Coelho GL, Gazzinelli G, Correa-Oliveira R, Tafuri WL.
    Acta Trop; 2007 Feb 13; 101(2):120-9. PubMed ID: 17296162
    [Abstract] [Full Text] [Related]

  • 16. Experimental Chagas' disease in orchiectomized Calomys callosus infected with the CM strain of Trypanosoma cruzi.
    Pinto AC, Caetano LC, Levy AM, Fernandes RD, Santos CD, do Prado JC.
    Exp Parasitol; 2010 Feb 13; 124(2):147-52. PubMed ID: 19698712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-arginine metabolism during interaction of Trypanosoma cruzi with host cells.
    Peluffo G, Piacenza L, Irigoín F, Alvarez MN, Radi R.
    Trends Parasitol; 2004 Aug 13; 20(8):363-9. PubMed ID: 15246319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.